Acute myeloid leukaemia (AML) statistics

Cases

New cases of acute myeloid leukaemia, 2014-2016 average, UK

Deaths

Deaths from acute myeloid leukaemia, 2016, UK

 

  • There are around 3,100 new acute myeloid leukaemia cases in the UK every year, that's more than 8 every day (2014-2016).
  • Acute myeloid leukaemia is not among the 20 most common cancers in the UK, accounting for less than 1% of all new cancer cases (2016).
  • In females in the UK, acute myeloid leukaemia is not among the 20 most common cancers, with around 1,300 new cases in 2016.
  • In males in the UK, acute myeloid leukaemia is not among the 20 most common cancers, with around 1,700 new cases in 2016.
  • Incidence rates for acute myeloid leukaemia in the UK are highest in people aged 85 to 89 (2014-2016).
  • Since the early 1990s, acute myeloid leukaemia incidence rates have increased by more than a quarter (29%) in the UK. Rates in females have increased by almost a quarter (23%) and rates in males have increased by almost a third (30%).
  • Over the last decade, acute myeloid leukaemia incidence rates have increased by almost a tenth (8%) in the UK. Rates in females have remained stable, and rates in males have increased by almost a tenth (8%).
  • Leukaemia (AML) in England is more common in males living in the most deprived areas. There is no association for females.
  • An estimated 6,100 people who had previously been diagnosed with acute myeloid leukaemia (AML) were alive in the UK at the end of 2010.

See more in-depth AML incidence statistics

  • There are around 2,500 acute myeloid leukaemia deaths in the UK every year, that's around 7 every day (2014-2016).
  • Acute myeloid leukaemia is not among the 20 most common causes of cancer death in the UK, accounting for 2% of all cancer deaths (2016).
  • In males in the UK, acute myeloid leukaemia is not among the 20 most common causes of cancer death, with around 1,500 deaths in 2016.
  • In females in the UK, acute myeloid leukaemia is not among the 20 most common causes of cancer death, with around 1,100 deaths in 2016.
  • Mortality rates for acute myeloid leukaemia in the UK are highest in people aged 85 to 89 (2014-2016).
  • Since the early 1970s, acute myeloid leukaemia mortality rates have increased by around four-fifths (79%) in the UK. Rates in males have increased by more than nine-tenths (92%), and rates in females have increased by almost three-fifths (58%).
  • Over the last decade, acute myeloid leukaemia mortality rates have remained stable in the UK. Rates in males have remained stable, and rates in females have remained stable.
  • Leukaemia (AML) deaths in England are not associated with deprivation.

See more in-depth AML mortality statistics

  • Five-year relative survival for acute myeloid leukaemia (AML) in men is similar to the European average in England, Wales and Scotland.
  • Five-year relative survival for acute myeloid leukaemia (AML) in women is below the European average in England but similar to the European average in Scotland.

See more in-depth AML survival statistics

  • ‘Two-week wait’ standards are met by all countries, and ‘31-day wait’ is met by all but England for acute leukaemia.

See more in-depth AML diagnosis and treatment statistics

Want the key stats in the sections on this page as a document? or looking for a stats report of the in-depth stats? Use the print function at the bottom of any Cancer Stats page Share this page > Print or your browser options to print or save.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or

Donate online

We’re now on twitter.
Join the conversation and follow @CRUKHCPs for news, updates and opinion.

@CRUKHCPs

The University of Manchester are currently conducting a survey into healthcare professionals' and public attitudes towards sun exposure and vitamin D.

Take part

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.